Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8
Closed -$2.99K 221
2024
Q2
$2.99K Buy
+8
New +$2.7K ﹤0.01% 254
2023
Q4
Sell
-303
Closed -$147K 227
2023
Q3
$147K Buy
303
+1
+0.3% +$470 0.04% 78
2023
Q2
$135K Hold
302
0.04% 80
2023
Q1
$147K Buy
302
+1
+0.3% +$494 0.04% 78
2022
Q4
$154K Hold
301
0.05% 75
2022
Q3
$146K Buy
301
+1
+0.3% +$486 0.05% 75
2022
Q2
$141K Hold
300
0.05% 77
2022
Q1
$131K Buy
+300
New +$125K 0.04% 82

Other funds holding HUM

Gleason Group's HUM Position: Q3 2024 in Review

Gleason Group sold out of Humana (HUM) in Q3 2024, closing a stake of 8 shares — an estimated $2.99K sold.

Gleason Group first reported a position in HUM in Q1 2022 and held it in 8 quarters. The position peaked at $154K in Q4 2022. 940 funds tracked by Wall St. Rank hold HUM as of Q3 2024.

  • Gleason Group reported no remaining Humana position as of Q3 2024 after selling out during the quarter.
  • Gleason Group sold 8 Humana shares in Q3 2024, an estimated $2.99K.
  • Gleason Group first reported a position in Humana in Q1 2022 and held it in 8 quarters.
  • Gleason Group's Humana position peaked at $154K in Q4 2022.
  • 940 funds tracked by Wall St. Rank held Humana as of Q3 2024.

Based on Gleason Group's 13F filing for Q3 2024, filed 15 Oct 2024.